Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC
Accepted 2022-08-09 00:00:00 ET · period of report 2022-08-05 · accession 0001209191-22-045056 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-09 | 2022-08-05 | ALXO | GARCIA PETER S | CFO | A - Grant | $0.00 | +29.0K | 55.2K | +111% | $0 |
| D | 2022-08-09 | 2022-08-05 | ALXO | GARCIA PETER S | CFO | A - Grant | $0.00 | +95.0K | 95.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-05 | A | A | 29,000 | $0.00 | 55,178 | D | — | — | (F1) The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2022. (F2) Includes 1,695 shares acquired under the Issuer's employee stock purchase plan on June 30, 2022. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2022-08-05 | A | A | 95,000 | $0.00 | 95,000 | D | $11.47 · — to 2032-08-04 | 95,000 Common Stock | (F3) Shares subject to the option vest in 48 equal monthly installments beginning on August 1, 2022. |